Prescription drug · NDA
Velphoro (Sucroferric oxyhydroxide) NDC 49230-645
Ferric oxyhydroxide 500 mg/1 · Tablet, Chewable · Oral · Fresenius Medical Care Renal Therapies Group, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 49230-645-51 | 49230064551 | 1 BOTTLE in 1 CARTON (49230-645-51) / 90 TABLET, CHEWABLE in 1 BOTTLEMarketed from Nov 27, 2013 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Velphoro
- Generic name (nonproprietary)
- sucroferric oxyhydroxide
- Active ingredients
- Ferric oxyhydroxide — 500 mg/1
- Dosage form
- Tablet, Chewable
- Route
- Oral
- Labeler
- Fresenius Medical Care Renal Therapies Group, LLCNDC labeler code 49230
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 205109
- Marketing start
- Listing expires
- Other FDA classes
- Phosphate Chelating Activity (Mechanism)
- Identifiers
- Product ID 49230-645_4e6c954e-7710-efc7-e063-6394a90a6dc2SPL ID 4e6c954e-7710-efc7-e063-6394a90a6dc2SPL set ID 237da26c-f38c-4faa-93ad-735e71c9d0c1RxCUI 1484289, 1484296UNII 87PZU03K0KUPC 0349230645514
- Pharmacologic class
- Phosphate Binder
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N449230064551followed by a unit qualifier and the quantityPackage 49230-0645-51. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Velphoro is indicated for the control of serum phosphorus levels in adults and pediatric patients 9 years of age and older with chronic kidney disease (CKD) on dialysis. Velphoro is a phosphate binder indicated for the control of serum phosphorus levels in adult and pediatric patients 9 years of age and older with chronic kidney disease on dialysis. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 49230-645
- What is NDC 49230-645?
- 49230-645 is the product NDC for Velphoro (sucroferric oxyhydroxide), Ferric oxyhydroxide 500 mg/1 tablet, chewable, listed with the FDA by Fresenius Medical Care Renal Therapies Group, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Velphoro (Sucroferric oxyhydroxide).
- What is the active ingredient?
- Ferric oxyhydroxide.
- Who is the labeler?
- Fresenius Medical Care Renal Therapies Group, LLC, NDC labeler code 49230. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Velphoro?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.